In February 2023, Mitsubishi Chemical Group announced its decision to stop Medicago Inc.’s operations. Medicago was a pharmaceutical company based in Quebec, Canada that made headlines at the height of the COVID-19 pandemic when it successfully used plant molecular farming to create COVIFENZ® COVID-
Krung Thep Mahanakhon United States United Kingdom Baiya Phytopharm Zabrinaj Bugnosen Mitsubishi Chemical Group
Source: isaaa.org